Search

Pharmagest Interactive

Uždarymo kaina

0

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

Max

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-1.8M

17M

Pardavimai

7.2M

116M

P/E

Sektoriaus vid.

16.213

Dividendų pajamingumas

3.08

Pelno marža

14.879

Darbuotojai

1,400

EBITDA

178M

116M

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.08%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-24M

583M

Ankstesnė atidarymo kaina

0

Ankstesnė uždarymo kaina

0

Pharmagest Interactive Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-03 21:44; UTC

Uždarbis

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

2025-11-03 23:44; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

2025-11-03 23:34; UTC

Rinkos pokalbiai

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

2025-11-03 23:28; UTC

Uždarbis

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

2025-11-03 23:24; UTC

Uždarbis

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025-11-03 23:14; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-11-03 23:14; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

2025-11-03 23:12; UTC

Uždarbis

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025-11-03 23:09; UTC

Uždarbis

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

2025-11-03 23:09; UTC

Uždarbis

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

2025-11-03 23:09; UTC

Uždarbis

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

2025-11-03 23:06; UTC

Rinkos pokalbiai
Uždarbis

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

2025-11-03 22:36; UTC

Rinkos pokalbiai
Uždarbis

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

2025-11-03 22:31; UTC

Uždarbis

Franco-Nevada 3Q EPS $1.49 >FNV

2025-11-03 22:31; UTC

Uždarbis

Franco-Nevada 3Q Rev $487.7M >FNV

2025-11-03 22:24; UTC

Rinkos pokalbiai

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

2025-11-03 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks Agrees to Sell Stake in China Business -- WSJ

2025-11-03 21:59; UTC

Rinkos pokalbiai

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

2025-11-03 21:54; UTC

Rinkos pokalbiai
Uždarbis

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

2025-11-03 21:54; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-11-03 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-03 21:49; UTC

Uždarbis

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

2025-11-03 21:40; UTC

Uždarbis

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

2025-11-03 21:31; UTC

Rinkos pokalbiai

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

2025-11-03 21:19; UTC

Uždarbis

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

2025-11-03 21:11; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

2025-11-03 21:11; UTC

Uždarbis

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

2025-11-03 21:07; UTC

Uždarbis

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

2025-11-03 21:05; UTC

Uždarbis

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

2025-11-03 21:05; UTC

Uždarbis

Palantir Technologies 3Q Net $475.6M >PLTR

Pharmagest Interactive Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Pharmagest Interactive

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat